John Sellers

Cooley advised Baseten, a company powering inference for the world’s fastest-growing artificial intelligence products, on its $150 million Series D financing, valuing the company at $2.15 billion.

Cooley advised EliseAI, an artificial intelligence company automating complex healthcare and housing systems, on the close of its $250 million Series E financing.

Cooley advised Jocasta Neuroscience, a preclinical-stage, longevity-focused company, on its $35 million Series A financing. Its lead asset, a proprietary formulation of the longevity protein a - Klotho, is used to treat a range of conditions, including cognitive impairment in neurodegenerative diseases.

Cooley advised Hadrian, a manufacturing company building artificial intelligence-powered factories for America, on its $260 million Series C financing round.

Cooley advised Harvey, a domain-specific artificial intelligence platform for legal and professional services, on its $300 million Series E at a $5 billion valuation.